Wenli Lin

596 total citations
8 papers, 469 citations indexed

About

Wenli Lin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Wenli Lin has authored 8 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Wenli Lin's work include Immune Cell Function and Interaction (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immune cells in cancer (2 papers). Wenli Lin is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immune cells in cancer (2 papers). Wenli Lin collaborates with scholars based in China, United States and Spain. Wenli Lin's co-authors include Aiqin Gao, Guangyong Peng, Fusheng Si, Yangjing Zhao, Lan Huang, Yuping Sun, Qixiang Shao, Xia Liu, Daniel F. Hoft and Eddy C. Hsueh and has published in prestigious journals such as FEBS Letters, Science Translational Medicine and Advanced Science.

In The Last Decade

Wenli Lin

8 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenli Lin China 7 261 153 146 127 56 8 469
Florence Picard France 3 308 1.2× 182 1.2× 157 1.1× 208 1.6× 54 1.0× 5 542
Ramya Sridharan United States 2 184 0.7× 316 2.1× 180 1.2× 59 0.5× 60 1.1× 3 507
Kung‐Chi Kao Switzerland 7 201 0.8× 133 0.9× 138 0.9× 92 0.7× 43 0.8× 9 417
Janina Dörr Germany 2 263 1.0× 177 1.2× 253 1.7× 59 0.5× 49 0.9× 2 530
Haining Li China 11 149 0.6× 237 1.5× 141 1.0× 139 1.1× 110 2.0× 22 482
Fédérica De Paoli France 8 227 0.9× 141 0.9× 120 0.8× 74 0.6× 26 0.5× 15 420
Meidi Gu United States 12 205 0.8× 204 1.3× 126 0.9× 132 1.0× 53 0.9× 14 443
Lorena Carmona‐Rodríguez Spain 9 154 0.6× 122 0.8× 104 0.7× 82 0.6× 30 0.5× 12 345

Countries citing papers authored by Wenli Lin

Since Specialization
Citations

This map shows the geographic impact of Wenli Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenli Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenli Lin more than expected).

Fields of papers citing papers by Wenli Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenli Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenli Lin. The network helps show where Wenli Lin may publish in the future.

Co-authorship network of co-authors of Wenli Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenli Lin. A scholar is included among the top collaborators of Wenli Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenli Lin. Wenli Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liu, Xia, Celine L. Hartman, Lingyun Li, et al.. (2021). Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13(587). 200 indexed citations
2.
Zhao, Yangjing, Xia Liu, Fusheng Si, et al.. (2021). Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy. Advanced Science. 9(1). e2101553–e2101553. 39 indexed citations
3.
Gao, Aiqin, Xia Liu, Wenli Lin, et al.. (2021). Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. Journal for ImmunoTherapy of Cancer. 9(3). e001536–e001536. 68 indexed citations
4.
Lin, Wenli, Nan‐Chang Chiu, Angela Huang, et al.. (2015). Management of Bacillus Calmette-Guérin osteomyelitis/osteitis in immunocompetent children—A systematic review. Vaccine. 33(36). 4391–4397. 39 indexed citations
5.
Zhang, Pei, Shuwen Yu, Hongyu Li, et al.. (2015). ILT4 drives B7‐H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7‐H3 co‐expression correlates with poor prognosis in non‐small cell lung cancer. FEBS Letters. 589(17). 2248–2256. 60 indexed citations
6.
Han, Bing, Qunyuan Zhang, Jie Dou, et al.. (2015). Vasohibin-1 suppresses colon cancer. Oncotarget. 6(10). 7880–7898. 21 indexed citations
7.
Liu, Jie, Linlin Wang, Wei Gao, et al.. (2014). Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10. Diagnostic Pathology. 9(1). 85–85. 40 indexed citations
8.
Kudo, Norio, et al.. (1976). Inhibitory action of colchicine on the secretory function of matrix formative cells in hard tissues. The Japanese Journal of Pharmacology. 26. 82–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026